EP2707005
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
:
EP einkaleyfi: Þýðing ekki lögð inn:
14.5.2012:
23.8.2017:
12719993.3
:
13.5.2032
:
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
14.5.2012
23.8.2017
:
CSL Behring GmbH:
Emil-von-Behring-Strasse 76, 35041, Marburg, DE
:
SCHULTE, Stefan:
Marburg, DE
:
KALINA, Uwe:
Marburg, DE
:
MOSES, Michael:
Grävenwiesbach, DE
:
FEUSSNER, Annette:
Marburg, DE
:
11165869:
12.5.2011:
EP
:
201161487205 P:
17.5.2011:
US
:
EP2012058954:
14.5.2012
:
A61K 31/727, A61K 35/16, A61K 38/57, A61P 7/02, A61P 1/00, A61P 11/08, A61P 9/06, A61P 9/12